[Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines] - PubMed (original) (raw)
[Article in Chinese]
Affiliations
- PMID: 10322719
Comparative Study
[Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines]
[Article in Chinese]
W Guo et al. Zhonghua Liu Xing Bing Xue Za Zhi. 1998 Apr.
Abstract
319 infants aged 5-18 months were divided in to 2 groups and immunized with Japanese encephalitis virus inactivated vaccine and live attenuated vaccine respectively. Under the detection of serum antibody, a 3.76% serum antibody positive rate was revealed before the immunization. However, after the basic immunization the serum positive rates of the two vaccines reached 59.56% and 56.08% respectively but still under the protective level. The infants were then given booster injection one year later. The serum positive rates reached 94.62% and 98.21% respectively 1 month later. When six months after the booster immunization, the positive rates were 72.34% and 94.74% respectively. According to the results, the following immunization order was recommend. For inactivated vaccine: 2 injections are given with an interval of 7-10 days for basic immunization and booster immunization be given in the second and third years. For live attenuated vaccine: one injection is given for basic immunization then booster dose be given in the second year and 4-5 years later.
Similar articles
- [Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].
Ma FB, Zheng L, Bi C, Tao H, Zhou YL, Zhang JL, Tang FY, Xie P, Zheng CZ, Peng WB, Jiang RJ. Ma FB, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Feb;24(2):113-5. Zhonghua Liu Xing Bing Xue Za Zhi. 2003. PMID: 12697111 Chinese. - Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P. Monath TP, et al. J Infect Dis. 2003 Oct 15;188(8):1213-30. doi: 10.1086/378356. Epub 2003 Oct 3. J Infect Dis. 2003. PMID: 14551893 Clinical Trial. - Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T, Sohn YM, Yoksan S, Min J, Ohrr H. Chotpitayasunondh T, et al. J Med Assoc Thai. 2011 Aug;94 Suppl 3:S195-203. J Med Assoc Thai. 2011. PMID: 22043776 - Japanese encephalitis: update on vaccines and vaccine recommendations.
Wilder-Smith A, Halstead SB. Wilder-Smith A, et al. Curr Opin Infect Dis. 2010 Oct;23(5):426-31. doi: 10.1097/QCO.0b013e32833c1d01. Curr Opin Infect Dis. 2010. PMID: 20581670 Review. - [Immunization against HIV. Problems in developing a vaccine].
Uhl D. Uhl D. Med Monatsschr Pharm. 1988 Nov;11(11):376-8. Med Monatsschr Pharm. 1988. PMID: 3059163 Review. German. No abstract available.
Cited by
- Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review.
Li X, Ma SJ, Liu X, Jiang LN, Zhou JH, Xiong YQ, Ding H, Chen Q. Li X, et al. Hum Vaccin Immunother. 2014;10(12):3579-93. doi: 10.4161/21645515.2014.980197. Hum Vaccin Immunother. 2014. PMID: 25668666 Free PMC article. Review. - Vaccines for preventing Japanese encephalitis.
Schiøler KL, Samuel M, Wai KL. Schiøler KL, et al. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004263. doi: 10.1002/14651858.CD004263.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636750 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical